Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis

doi:10.3748/wjg.v19.i22.3481

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6135)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

461

HTML

2994

Figures (1-2)

222

Tables (1-2)

240

Sum=3917

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1142

Download

1076

Sum=2218

Jun 14, 2013 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 14, 2013; 19(22): 3481-3486
Published online Jun 14, 2013. doi: 10.3748/wjg.v19.i22.3481

Full Size Figure Download Figure

Figure 1 Flow chart of patients disposition in de novo lamivudine and adefovir dipivoxil combination group and lamivudine monotherapy group. HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; ADV: Adefovir dipivoxil; LAM: Lamivudine.

Citation: Lv GC, Yao JM, Yang YD, Zheng L, Sheng JF, Chen Y, Li LJ. Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis. World J Gastroenterol 2013; 19(22): 3481-3486
URL: https://www.wjgnet.com/1007-9327/full/v19/i22/3481.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i22.3481